Analytical Data
-
Gene name
BAT4
- Application
-
Alternative Names
BARX1Homeobox Protein BarH-like 1
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9HBU1
-
Expression Region
1-356aa
-
AA Sequence
MSRPLLITFTPATDPSDLWKDGQQQPQPEKPESTLDGAAARAFYEALIGDESSAPDSQRSQTEPARERKRKKRRIMKAPAAEAVAEGASGRHGQGRSLEAEDKMTHRILRAAQEGDLPELRRLLEPHEAGGAGGNINARDAFWWTPLMCAARAGQGAAVSYLLGRGAAWVGVCELSGRDAAQLAEEAGFPEVARMVRESHGETRSPENRSPTPSLQYCENCDTHFQDSNHRTSTAHLLSLSQGPQPPNLPLGVPISSPGFKLLLRGGWEPGMGLGPRGEGRANPIPTVLKRDQEGLGYRSAPQPRVTHFPAWDTRAVAGRERPPRVATLSWREERRREEKDRAWERDLRTYMNLEF
-
Molecular Weight
65.7 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The research on BAT4 recombinant proteins has gained significant attention in recent years due to their potential applications in biotechnology and medicine. BAT4, a novel protein identified in various biological systems, plays a critical role in immune modulation and cellular processes. Initial studies suggested that BAT4 may enhance immune responses, making it a candidate for developing vaccines and immunotherapies. Additionally, the protein’s unique structure and functional properties prompt interest in its enzymatic activities, which could be leveraged for industrial applications, such as biocatalysis. As researchers continue to explore the mechanisms of BAT4 action, recombinant technology allows for the mass production of these proteins, enabling detailed studies on their efficacy and safety. This line of research also opens up possibilities for engineering BAT4 variants with optimized properties for specific applications. Thus, understanding BAT4 at the molecular level not only contributes to fundamental biological knowledge but also paves the way for innovative solutions in therapeutic strategies, highlighting the importance of these recombinant proteins in the intersection of biology and technology.
